Medicare Prescription Drug Coverage: Facts, Options, and Implications
Testimony by Patricia Neuman, Sc.D.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
Testimony by Patricia Neuman, Sc.D.
With attention focused recently on direct-to-consumer advertising of prescription drugs, findings from a new National Survey of Physicians by the Kaiser Family Foundation shed light on another factor in drug promotion that has received less attention -- promotion to physicians.
This testimony was delivered by Tricia Neuman, a vice president of the Kaiser Family Foundation, at a Senate Finance Committee hearing on the Bush Administration's Proposals for Medicare Modernization.
Health News Index July/August, 2002 The Health News Index measures public attention to and knowledge about leading health stories covered in the news in June and July, including discussions in Congress about a Medicare prescription drug benefit; a report from the National Institutes of Health on hormone replacement therapy; and the International AIDS Conference in…
Recent Publications on Medicaid and Prescription Drugs The Kaiser Commission on Medicaid and the Uninsured continues to focus on the role of prescription drugs in the Medicaid program with particular attention on drug spending trends, state reforms to curb spending, and the impact on access to care.
As policymakers consider a range of approaches to providing prescription drug coverage to the Medicare population in today s tight budgetary environment, one proposal that has been put forth by the Bush Administration is that of a Medicare-endorsed prescription drug discount card program.
Florida's Medicaid Prescription Drug Benefit: A Case Study A new study summarizes and discusses the state s attempt to reform its Medicaid prescription drug benefit program.
This report by Michael Gluck of the Georgetown University Institute for Health Care Research and Policy examines several ways in which the federal government influences the availability and cost of prescription drugs, including 1) intellectual property protection the laws and policies which regulate and influence patents and generic competition (include the Hatch-Waxman Act), 2) federal…
This paper, featured in the February 27, 2002, online issue of Health Affairs, examines trends in Medicare beneficiaries supplemental insurance and prescription drug coverage between 1996 and 1999, using the Medicare Current Beneficiary Survey (MCBS) Access to Care files. It also provides snapshot estimates of coverage among subgroups of Medicare beneficiaries in 1999.
Medicaid: Purchasing Prescription Drugs A policy brief explaining how Medicaid purchases outpatient drugs and outlining the policy tools available to states to limit the rate of growth in spending on prescription drugs.
© 2026 KFF